← Eichor
Condition: Still Disease Juvenile Onset Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Still Disease Juvenile Onset

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Natural History, Genetics, and Pathophysiology of Systemic Juvenile Idiopathic Arthritis, Adult-Onset Still's Disease, a
Phase N/A · 1 location(s) · National Institute of Arthritis and Musculoskeletal and Skin · NCT03510442
A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients
Phase N/A · 1 location(s) · Novartis Pharmaceuticals · NCT07517250
AutoInflammatory Disease Alliance Registry (AIDA)
Phase N/A · 112 location(s) · University of Siena · NCT05200715
Rheumatology Patient Registry and Biorepository
Phase N/A · 1 location(s) · Yale University · NCT04402086
Acostill ( RaDiCo Cohort) (RaDiCo Acostill)
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT05927454
EACVI Study on Multimodality Cardiovascular Imaging of Inflammatory Cardiovascular Diseases
Phase N/A · 1 location(s) · Assistance Publique - Hôpitaux de Paris · NCT07077304
Glycosylated Ferritin in Macrophagic Activation Syndromes
Phase N/A · 1 location(s) · Brugmann University Hospital · NCT02143986
A Phase II Trial to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Pediatric and Adult Participant
Phase 2 · 22 location(s) · Novartis Pharmaceuticals · NCT07203001
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.